HIV Prevention for Women: Five Studies Explained

Five published studies on HIV prevention in women, explained in plain language: what each one tested, what it found, and what the studies cannot tell us. New medical research, translated into your everyday life. Chapters 0:00 Introduction 0:53 The VOICE trial 2:25 The Ring Study 3:48 ASPIRE 5:08 The CAPRISA analysis 6:13 PURPOSE One 7:49 Three patterns across the studies 9:05 What these studies cannot tell us 9:40 What to take from this Studies covered The VOICE trial: Tenofovir-based preexposure prophylaxis for HIV infection among African women. The New England journal of medicine (2015). https://doi.org/10.1056/NEJMoa1402269 The Ring Study: Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. The New England journal of medicine (2016). https://doi.org/10.1056/NEJMoa1602046 ASPIRE: Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. The New England journal of medicine (2016). https://doi.org/10.1056/NEJMoa1506110 The CAPRISA analysis: Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science (New York, N.Y.) (2017). https://doi.org/10.1126/science.aai9383 PURPOSE One: Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. The New England journal of medicine (2024). https://doi.org/10.1056/NEJMoa2407001 For education only. Diagnosis and treatment decisions belong to your clinician. Footage: Pixabay (Pixabay Content License). Music: "Easy Lemon" and "Touching Moments Two - Higher" by Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 4.0 License http://creativecommons.org/licenses/by/4.0/ Music trimmed, cross-faded and lowered under the narration.